Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Adolescent 40
- Adult 78
- Adverse Drug Reaction Reporting Systems 30
- Aged 17
- Age Factors 13
- Anthrax Vaccines 11
- BNT162 Vaccine 11
- Chikungunya Fever/prevention & control 14
- Child 67
- Child, Preschool 30
- Clinical Laboratory Services 14
- Communication 16
- Coronavirus Infections 25
- Coronavirus Infections/prevention & control 163
- Coronavirus Infections/prevention &control 47
- COVID-19 94
- COVID-19 Vaccines 223
- COVID-19 Vaccines/adverse effects 22
- COVID-19/prevention & control 101
- Data Collection 138
- Decision Making 33
- Dengue 16
- Dengue/prevention & control 12
- Dengue Vaccines 31
- Disaster Planning 21
- Disease Outbreaks 36
- Drug-Related Side Effects and Adverse Reactions 14
- Ebola Vaccines 17
- Environmental Exposure 14
- Female 21
- Global Health 19
- GRADE Approach 52
- Hazardous Substances 16
- Health Equity 13
- Health Personnel 23
- Health Promotion 19
- Health Surveys 160
- Hepatitis A Vaccines 16
- Hepatitis B Vaccines 26
- Herpes Zoster Vaccine 33
- Humans 13
- Immunization 40
- Immunization, Secondary 61
- Immunization/standards 32
- Immunization Programs 37
- Immunization Schedule 45
- Infant 31
- Infant, Newborn 44
- Infection Control 25
- Influenza, Human 22
- Influenza, Human/prevention & control 20
- Influenza Vaccines 138
- Influenza Vaccines 12
- Information Dissemination 15
- Japanese Encephalitis Vaccines 26
- Laboratories 22
- Lead/blood 15
- Mass Media 12
- Measles-Mumps-Rubella Vaccine 20
- Meningococcal Vaccines 76
- Mpox (monkeypox)/prevention & control 14
- Occupational Exposure/prevention & control 13
- Pandemics 148
- Papillomavirus Vaccines 46
- Papillomavirus Vaccines 34
- Patient Safety 53
- Pertussis Vaccine 28
- Pneumococcal Infections 13
- Pneumococcal Vaccines 72
- Population Surveillance 14
- Pregnancy 37
- Pregnant Women 25
- Program Evaluation 18
- Public Health 35
- Public Health Administration 13
- Public Health Informatics 17
- Public Health Surveillance 48
- Public Relations 12
- Respiratory Syncytial Virus Infections/prevention & control 56
- Respiratory Syncytial Virus Infections/prevention & Control 14
- Respiratory Syncytial Virus Vaccines 48
- Respiratory Syncytial Virus Vaccines/economics 13
- Safety 30
- SARS-CoV-2 13
- Smallpox Vaccine 22
- Surveys and Questionnaires 78
- Surveys And Questionnaires 71
- Travel 13
- United States Government Agencies 21
- Vaccination 251
- Vaccination/adverse effects 16
- Vaccine Efficacy 13
- Vaccines 72
- Vaccines, Combined 14
- Vaccines/administration & dosage 32
- Vaccines/supply & distribution 17
- Viral Vaccines 128
- Vital Statistics 143
- Young Adult 23
- Zika Virus Infection 19
Personal Author
- Anderson, Robert N. 5
- Ault, Kevin 5
- Bell, Beth P. 21
- Belongia, Edward A. 7
- Bennett, Nancy M. 13
- Bernstein, Henry H. 4
- Blumberg, Stephen 6
- Bocchini, Joseph A. 15
- Bower, William A. 7
- Brammer, Lynnette 11
- Branum, Amy 4
- Britton, Amadea 7
- Brooks, Oliver 4
- Chen, Wilbur 10
- Chesson, Harrell W. 4
- Choi, Mary 5
- Chung, Jessie R. 7
- Clark, Thomas A. 4
- Cohn, Amanda C. 16
- Collins, Jennifer 4
- Coyne-Beasley, Tamera 4
- Crowe, Sam 4
- Daley, Matthew F. 24
- Das, Rituparna 6
- DeFrances, Carol 5
- Dooling, Kathleen 22
- Duchin, Jeffrey S. 6
- Fischer, Marc 5
- Flannery, Brendan 11
- Fleming, David 5
- Frey, Sharon 8
- Gargano, Julia W. 5
- Gierke, Ryan 6
- Grohskopf, Lisa A. 37
- Hall, Elisha 6
- Havers, Fiona 5
- Hills, Susan 13
- Hills, Susan L. 17
- Hopkins, Robert H. 12
- Hutton, David W. 8
- Jones, Jefferson 10
- Karron, Ruth A. 8
- Kempe, Allison 5
- Kim, David K. 6
- Klein, Nicola P. 6
- Kobayashi, Miwako 16
- Kotton, Camille 6
- Kroger, Andrew T. 13
- Lee, Grace M. 18
- Liang, Jennifer L. 10
- Liburd, Leandris 5
- Link-Gelles, Ruth 10
- Loehr, Jamie 7
- Long, Sarah S. 6
- Luxembourg, Alain 7
- MacNeil, Jessica 13
- Markowitz, Lauri E. 27
- Matanock, Almea 6
- Mbaeyi, Sarah A. 7
- Meites, Elissa 6
- Melgar, Michael 8
- Moore, Kelly L. 7
- Moro, Pedro L. 5
- Moyer, Brian C. 10
- Murthy, Neil 5
- Nelson, Noele 10
- Oliver, Sara E. 40
- Ortega-Sanchez, Ismael R. 7
- Paz-Bailey, Gabriela 5
- Petersen, Brett W. 5
- Pickering, Larry K. 5
- Pilishvili, Tamara 16
- Poehling, Katherine 9
- Poehling, Katherine A. 13
- Prosser, Lisa A. 5
- Rao, Agam 14
- Reingold, Arthur 16
- Reynolds, Barbara (Barbara S.) 11
- Riley, Laura E. 5
- Robinson, Candice L. 6
- Romero, José R. 13
- Rubin, Lorry 10
- Sanchez, Pablo 8
- Santoli, Jeanne M. 26
- Sawyer, Mark 6
- Shimabukuro, Tom T. 41
- Sondik, Edward J. 6
- Staples, J. Erin 5
- Stephens, David S. 11
- Stoecker, Charles 6
- Stokley, Shannon 5
- Sutton, Paul D. 5
- Sylvester, Gregg C. 7
- Szilagyi, Peter 5
- Talbot, H. Keipp 16
- Temte, Jonathan L. 7
- Thornburg, Natalie J. 5
- Twentyman, Evelyn 6
- Wallace, Megan 11
- Walter, Emmanuel B. 17
Corporate Author
- CDC COVID-19 Vaccine Planning Unit. Vaccine Safety Team. 6
- CDC COVID-19 Vaccine Task Force. Vaccine Safety Team. 14
- Center for Preparedness and Response (U.S.). Division of Select Agents and Toxins. 5
- Center for Surveillance, Epidemiology, and Laboratory Services (U.S.). Division of Laboratory Systems. 8
- Centers for Disease Control and Prevention (U.S) 16
- Centers for Disease Control and Prevention (U.S). Office for Public Health Preparedness and Response. 13
- Centers for Disease Control and Prevention (U.S.) 42
- Centers for Disease Control and Prevention (U.S.). Advisory Committee to the Director. 7
- Centers for Disease Control and Prevention (U.S.). Clinical Laboratory Improvement Advisory Committee. 7
- Centers for Disease Control and Prevention (U.S.). Office for State, Tribal, Local and Territorial Support. 11
- COVID-19 Vaccine Safety Technical (VaST) Work Group. 9
- GlaxoSmithKline. 4
- GSK Vaccines. 10
- Healthcare Infection Control Practices Advisory Committee (U.S.). Infection Control in Healthcare Personnel Workgroup. 9
- HealthPartners Institute. Vaccine Safety Datalink Team. 4
- Janssen Pharmaceuticals Companies of Johnson & Johnson. 4
- Kaiser Permanente Vaccine Study Center. 8
- Marshfield Clinic Research Institute. 6
- Marshfield Clinic Research Institute. Vaccine Safety Datalink. Immunization Safety Office. 5
- MedImmune, Inc. 5
- Merck Research Laboratories. 12
- Moderna (firm) 10
- National Center for Chronic Disease Prevention and Health Promotion (U.S.), Division of Nutrition, Physical Activity, and Obesity. 6
- National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control. 7
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Arboviral Diseases Branch. 4
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases. 6
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. 8
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Immunization Safety Office. 16
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. 13
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Poxvirus and Rabies Branch. 11
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Viral Special Pathogens Branch. 6
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. Arboviral Diseases Branch. 27
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. Dengue Branch. 8
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office. 22
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Poxvirus and Rabies Branch. 4
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Viral Special Pathogens Branch. 6
- National Center for Environmental Health (U.S.) 4
- National Center for Health Statistics (U.S.) 71
- National Center for Health Statistics (U.S.). Board of Scientific Counselors. 8
- National Center for Health Statistics (U.S.). Board of Scientific Counselors. Meeting. 11
- National Center for Health Statistics (U.S.). Division of Analysis and Epidemiology. 4
- National Center for Health Statistics (U.S.). Division of Health and Nutrition Examination Surveys. 7
- National Center for Health Statistics (U.S.). Division of Health Care Statistics. 9
- National Center for Health Statistics (U.S.). Division of Health Interview Statistics. 11
- National Center for Health Statistics (U.S.). Division of Research and Methodology. 5
- National Center for Health Statistics (U.S.). Division of Vital Statistics. 6
- National Center for Health Statistics (U.S.). Division of Vital Statistics. Mortality Statistics Branch. 4
- National Center for HIV, STD, and TB Prevention (U.S.). Division of STD Prevention. 4
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.) 11
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Adolescent and School Health. 7
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention. 4
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention. 10
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis. 10
- National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of Viral Hepatitis. 6
- National Center for Immunization and Respiratory Diseases (U.S.) 76
- National Center for Immunization and Respiratory Diseases (U.S.). Coronavirus and Other Respiratory Viruses Division. 7
- National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases. 34
- National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. 64
- National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. 71
- National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. 38
- National Center for Immunization and Respiratory Diseases (U.S.). Meningitis and Vaccine Preventable Diseases Branch. 6
- National Center for Immunization and Respiratory Diseases (U.S.). Respiratory Diseases Branch. 9
- National Center for Immunization and Respiratory Diseases (U.S.). US Flu VE Network. 10
- National Center for Immunizations and Respiratory Diseases (U.S.). Respiratory Diseases Branch. 6
- National Center for Injury Prevention and Control (U.S.) 6
- National Center for Injury Prevention and Control (U.S.). Division of Unintentional Injury Prevention. 6
- Pfizer Ltd. 9
- Sanofi Pasteur. 9
- Seqirus. 6
- Tulane University. School of Public Health and Tropical Medicine. 6
- United States. Advisory Committee on Immunization Practices. 53
- United States. Advisory Committee on Immunization Practices. ACIP Flavivirus Vaccines Workgroup. 6
- United States. Advisory Committee on Immunization Practices. Adult Immunization Work Group. 10
- United States. Advisory Committee on Immunization Practices. Adult RSV Work Group. 15
- United States. Advisory Committee on Immunization Practices. Anthrax Vaccine Work Group. 11
- United States. Advisory Committee on Immunization Practices. Chikungunya Vaccines Work Group. 14
- United States. Advisory Committee on Immunization Practices. Combined Immunization Schedule Work Group. 5
- United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. 148
- United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. COVID-19 Vaccine Safety Technical (VaST) Subgroup. 5
- United States. Advisory Committee on Immunization Practices. Dengue Vaccine Workgroup. 7
- United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group. 33
- United States. Advisory Committee on Immunization Practices. Herpes Zoster Work Group. 14
- United States. Advisory Committee on Immunization Practices. HPV Vaccines Work Group. 9
- United States. Advisory Committee on Immunization Practices. Human Rabies Prevention Work Group. 10
- United States. Advisory Committee on Immunization Practices. Influenza Work Group. 29
- United States. Advisory Committee on Immunization Practices. Influenza Workgroup. 6
- United States. Advisory Committee on Immunization Practices. JE Flavivirus Vaccine Workgroup. 5
- United States. Advisory Committee on Immunization Practices. Maternal/Pediatric Respiratory Syncytial Virus (RSV) Work Group. 7
- United States. Advisory Committee on Immunization Practices. Measles, Mumps, and Rubella (MMR) Vaccine Work Group. 5
- United States. Advisory Committee on Immunization Practices. Meningococcal Vaccines Work Group. 18
- United States. Advisory Committee on Immunization Practices. Meningococcal Work Group. 15
- United States. Advisory Committee on Immunization Practices. Mpox Vaccine Work Group. 9
- United States. Advisory Committee on Immunization Practices. Mumps Work Group. 5
- United States. Advisory Committee on Immunization Practices. Pertussis Vaccines Work Group. 18
- United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group. 46
- United States. Advisory Committee on Immunization Practices. Zoster Working Group. 5
- United States. Animal and Plant Health Inspection Service. Agriculture Select Agent Program. 5
- United States. Public Health Service. 7
- University of Michigan. School of Public Health. 7
- Valneva 5
Place as Subject
- Africa, Western 3
- Alaska 2
- Anniston, AL 1
- Arctic Regions 2
- Asia 2
- Australia 1
- California 1
- Canada 2
- Chamblee, GA 1
- Chicago, Illinois 1
- Cleveland, OH 1
- Colorado 1
- Finland 2
- Greenland 2
- Haiti 1
- Herpes Zoster/prevention & control 1
- Herpes Zoster Vaccine 1
- Iceland 2
- Illinois 1
- Michigan 1
- Norway 2
- Ohio 1
- Paraguay 1
- Puerto Rico 6
- Rhode Island 2
- Sierra Leone 1
- Sweden 2
- Tennessee 1
- Uniged States 1
- United States 362
- Washington 2
- Washington, DC 1
- West Virginia 1
- Wisconsin 1
Resource Type General
- Presentation (2270)
Resource Type Specific
x
Presentation
Select all docs
(Max 200)
(Max 200)
1 -
20 of 2270 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Adolescent (40)
- Adult (78)
- Adverse Drug Reaction Reporting Systems (30)
- Aged (17)
- Age Factors (13)
- Anthrax Vaccines (11)
- BNT162 Vaccine (11)
- Chikungunya Fever/prevention & control (14)
- Child (67)
- Child, Preschool (30)
- Clinical Laboratory Services (14)
- Communication (16)
- Coronavirus Infections (25)
- Coronavirus Infections/prevention & control (163)
- Coronavirus Infections/prevention &control (47)
- COVID-19 (94)
- COVID-19 Vaccines (223)
- COVID-19 Vaccines/adverse effects (22)
- COVID-19/prevention & control (101)
- Data Collection (138)
- Decision Making (33)
- Dengue (16)
- Dengue/prevention & control (12)
- Dengue Vaccines (31)
- Disaster Planning (21)
- Disease Outbreaks (36)
- Drug-Related Side Effects and Adverse Reactions (14)
- Ebola Vaccines (17)
- Environmental Exposure (14)
- Female (21)
- Global Health (19)
- GRADE Approach (52)
- Hazardous Substances (16)
- Health Equity (13)
- Health Personnel (23)
- Health Promotion (19)
- Health Surveys (160)
- Hepatitis A Vaccines (16)
- Hepatitis B Vaccines (26)
- Herpes Zoster Vaccine (33)
- Humans (13)
- Immunization (40)
- Immunization, Secondary (61)
- Immunization/standards (32)
- Immunization Programs (37)
- Immunization Schedule (45)
- Infant (31)
- Infant, Newborn (44)
- Infection Control (25)
- Influenza, Human (22)
- Influenza, Human/prevention & control (20)
- Influenza Vaccines (138)
- Influenza Vaccines (12)
- Information Dissemination (15)
- Japanese Encephalitis Vaccines (26)
- Laboratories (22)
- Lead/blood (15)
- Mass Media (12)
- Measles-Mumps-Rubella Vaccine (20)
- Meningococcal Vaccines (76)
- Mpox (monkeypox)/prevention & control (14)
- Occupational Exposure/prevention & control (13)
- Pandemics (148)
- Papillomavirus Vaccines (46)
- Papillomavirus Vaccines (34)
- Patient Safety (53)
- Pertussis Vaccine (28)
- Pneumococcal Infections (13)
- Pneumococcal Vaccines (72)
- Population Surveillance (14)
- Pregnancy (37)
- Pregnant Women (25)
- Program Evaluation (18)
- Public Health (35)
- Public Health Administration (13)
- Public Health Informatics (17)
- Public Health Surveillance (48)
- Public Relations (12)
- Respiratory Syncytial Virus Infections/prevention & control (56)
- Respiratory Syncytial Virus Infections/prevention & Control (14)
- Respiratory Syncytial Virus Vaccines (48)
- Respiratory Syncytial Virus Vaccines/economics (13)
- Safety (30)
- SARS-CoV-2 (13)
- Smallpox Vaccine (22)
- Surveys and Questionnaires (78)
- Surveys And Questionnaires (71)
- Travel (13)
- United States Government Agencies (21)
- Vaccination (251)
- Vaccination/adverse effects (16)
- Vaccine Efficacy (13)
- Vaccines (72)
- Vaccines, Combined (14)
- Vaccines/administration & dosage (32)
- Vaccines/supply & distribution (17)
- Viral Vaccines (128)
- Vital Statistics (143)
- Young Adult (23)
- Zika Virus Infection (19)
- Anderson, Robert N. (5)
- Ault, Kevin (5)
- Bell, Beth P. (21)
- Belongia, Edward A. (7)
- Bennett, Nancy M. (13)
- Bernstein, Henry H. (4)
- Blumberg, Stephen (6)
- Bocchini, Joseph A. (15)
- Bower, William A. (7)
- Brammer, Lynnette (11)
- Branum, Amy (4)
- Britton, Amadea (7)
- Brooks, Oliver (4)
- Chen, Wilbur (10)
- Chesson, Harrell W. (4)
- Choi, Mary (5)
- Chung, Jessie R. (7)
- Clark, Thomas A. (4)
- Cohn, Amanda C. (16)
- Collins, Jennifer (4)
- Coyne-Beasley, Tamera (4)
- Crowe, Sam (4)
- Daley, Matthew F. (24)
- Das, Rituparna (6)
- DeFrances, Carol (5)
- Dooling, Kathleen (22)
- Duchin, Jeffrey S. (6)
- Fischer, Marc (5)
- Flannery, Brendan (11)
- Fleming, David (5)
- Frey, Sharon (8)
- Gargano, Julia W. (5)
- Gierke, Ryan (6)
- Grohskopf, Lisa A. (37)
- Hall, Elisha (6)
- Havers, Fiona (5)
- Hills, Susan (13)
- Hills, Susan L. (17)
- Hopkins, Robert H. (12)
- Hutton, David W. (8)
- Jones, Jefferson (10)
- Karron, Ruth A. (8)
- Kempe, Allison (5)
- Kim, David K. (6)
- Klein, Nicola P. (6)
- Kobayashi, Miwako (16)
- Kotton, Camille (6)
- Kroger, Andrew T. (13)
- Lee, Grace M. (18)
- Liang, Jennifer L. (10)
- Liburd, Leandris (5)
- Link-Gelles, Ruth (10)
- Loehr, Jamie (7)
- Long, Sarah S. (6)
- Luxembourg, Alain (7)
- MacNeil, Jessica (13)
- Markowitz, Lauri E. (27)
- Matanock, Almea (6)
- Mbaeyi, Sarah A. (7)
- Meites, Elissa (6)
- Melgar, Michael (8)
- Moore, Kelly L. (7)
- Moro, Pedro L. (5)
- Moyer, Brian C. (10)
- Murthy, Neil (5)
- Nelson, Noele (10)
- Oliver, Sara E. (40)
- Ortega-Sanchez, Ismael R. (7)
- Paz-Bailey, Gabriela (5)
- Petersen, Brett W. (5)
- Pickering, Larry K. (5)
- Pilishvili, Tamara (16)
- Poehling, Katherine (9)
- Poehling, Katherine A. (13)
- Prosser, Lisa A. (5)
- Rao, Agam (14)
- Reingold, Arthur (16)
- Reynolds, Barbara (Barbara S.) (11)
- Riley, Laura E. (5)
- Robinson, Candice L. (6)
- Romero, José R. (13)
- Rubin, Lorry (10)
- Sanchez, Pablo (8)
- Santoli, Jeanne M. (26)
- Sawyer, Mark (6)
- Shimabukuro, Tom T. (41)
- Sondik, Edward J. (6)
- Staples, J. Erin (5)
- Stephens, David S. (11)
- Stoecker, Charles (6)
- Stokley, Shannon (5)
- Sutton, Paul D. (5)
- Sylvester, Gregg C. (7)
- Szilagyi, Peter (5)
- Talbot, H. Keipp (16)
- Temte, Jonathan L. (7)
- Thornburg, Natalie J. (5)
- Twentyman, Evelyn (6)
- Wallace, Megan (11)
- Walter, Emmanuel B. (17)
- CDC COVID-19 Vaccine Planning Unit. Vaccine Safety Team. (6)
- CDC COVID-19 Vaccine Task Force. Vaccine Safety Team. (14)
- Center for Preparedness and Response (U.S.). Division of Select Agents and Toxins. (5)
- Center for Surveillance, Epidemiology, and Laboratory Services (U.S.). Division of Laboratory Systems. (8)
- Centers for Disease Control and Prevention (U.S) (16)
- Centers for Disease Control and Prevention (U.S). Office for Public Health Preparedness and Response. (13)
- Centers for Disease Control and Prevention (U.S.) (42)
- Centers for Disease Control and Prevention (U.S.). Advisory Committee to the Director. (7)
- Centers for Disease Control and Prevention (U.S.). Clinical Laboratory Improvement Advisory Committee. (7)
- Centers for Disease Control and Prevention (U.S.). Office for State, Tribal, Local and Territorial Support. (11)
- COVID-19 Vaccine Safety Technical (VaST) Work Group. (9)
- GlaxoSmithKline. (4)
- GSK Vaccines. (10)
- Healthcare Infection Control Practices Advisory Committee (U.S.). Infection Control in Healthcare Personnel Workgroup. (9)
- HealthPartners Institute. Vaccine Safety Datalink Team. (4)
- Janssen Pharmaceuticals Companies of Johnson & Johnson. (4)
- Kaiser Permanente Vaccine Study Center. (8)
- Marshfield Clinic Research Institute. (6)
- Marshfield Clinic Research Institute. Vaccine Safety Datalink. Immunization Safety Office. (5)
- MedImmune, Inc. (5)
- Merck Research Laboratories. (12)
- Moderna (firm) (10)
- National Center for Chronic Disease Prevention and Health Promotion (U.S.), Division of Nutrition, Physical Activity, and Obesity. (6)
- National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control. (7)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Arboviral Diseases Branch. (4)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases. (6)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. (8)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Immunization Safety Office. (16)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. (13)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Poxvirus and Rabies Branch. (11)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Viral Special Pathogens Branch. (6)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. Arboviral Diseases Branch. (27)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. Dengue Branch. (8)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office. (22)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Poxvirus and Rabies Branch. (4)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Viral Special Pathogens Branch. (6)
- National Center for Environmental Health (U.S.) (4)
- National Center for Health Statistics (U.S.) (71)
- National Center for Health Statistics (U.S.). Board of Scientific Counselors. (8)
- National Center for Health Statistics (U.S.). Board of Scientific Counselors. Meeting. (11)
- National Center for Health Statistics (U.S.). Division of Analysis and Epidemiology. (4)
- National Center for Health Statistics (U.S.). Division of Health and Nutrition Examination Surveys. (7)
- National Center for Health Statistics (U.S.). Division of Health Care Statistics. (9)
- National Center for Health Statistics (U.S.). Division of Health Interview Statistics. (11)
- National Center for Health Statistics (U.S.). Division of Research and Methodology. (5)
- National Center for Health Statistics (U.S.). Division of Vital Statistics. (6)
- National Center for Health Statistics (U.S.). Division of Vital Statistics. Mortality Statistics Branch. (4)
- National Center for HIV, STD, and TB Prevention (U.S.). Division of STD Prevention. (4)
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.) (11)
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Adolescent and School Health. (7)
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention. (4)
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention. (10)
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis. (10)
- National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of Viral Hepatitis. (6)
- National Center for Immunization and Respiratory Diseases (U.S.) (76)
- National Center for Immunization and Respiratory Diseases (U.S.). Coronavirus and Other Respiratory Viruses Division. (7)
- National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases. (34)
- National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (64)
- National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. (71)
- National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. (38)
- National Center for Immunization and Respiratory Diseases (U.S.). Meningitis and Vaccine Preventable Diseases Branch. (6)
- National Center for Immunization and Respiratory Diseases (U.S.). Respiratory Diseases Branch. (9)
- National Center for Immunization and Respiratory Diseases (U.S.). US Flu VE Network. (10)
- National Center for Immunizations and Respiratory Diseases (U.S.). Respiratory Diseases Branch. (6)
- National Center for Injury Prevention and Control (U.S.) (6)
- National Center for Injury Prevention and Control (U.S.). Division of Unintentional Injury Prevention. (6)
- Pfizer Ltd. (9)
- Sanofi Pasteur. (9)
- Seqirus. (6)
- Tulane University. School of Public Health and Tropical Medicine. (6)
- United States. Advisory Committee on Immunization Practices. (53)
- United States. Advisory Committee on Immunization Practices. ACIP Flavivirus Vaccines Workgroup. (6)
- United States. Advisory Committee on Immunization Practices. Adult Immunization Work Group. (10)
- United States. Advisory Committee on Immunization Practices. Adult RSV Work Group. (15)
- United States. Advisory Committee on Immunization Practices. Anthrax Vaccine Work Group. (11)
- United States. Advisory Committee on Immunization Practices. Chikungunya Vaccines Work Group. (14)
- United States. Advisory Committee on Immunization Practices. Combined Immunization Schedule Work Group. (5)
- United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. (148)
- United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. COVID-19 Vaccine Safety Technical (VaST) Subgroup. (5)
- United States. Advisory Committee on Immunization Practices. Dengue Vaccine Workgroup. (7)
- United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group. (33)
- United States. Advisory Committee on Immunization Practices. Herpes Zoster Work Group. (14)
- United States. Advisory Committee on Immunization Practices. HPV Vaccines Work Group. (9)
- United States. Advisory Committee on Immunization Practices. Human Rabies Prevention Work Group. (10)
- United States. Advisory Committee on Immunization Practices. Influenza Work Group. (29)
- United States. Advisory Committee on Immunization Practices. Influenza Workgroup. (6)
- United States. Advisory Committee on Immunization Practices. JE Flavivirus Vaccine Workgroup. (5)
- United States. Advisory Committee on Immunization Practices. Maternal/Pediatric Respiratory Syncytial Virus (RSV) Work Group. (7)
- United States. Advisory Committee on Immunization Practices. Measles, Mumps, and Rubella (MMR) Vaccine Work Group. (5)
- United States. Advisory Committee on Immunization Practices. Meningococcal Vaccines Work Group. (18)
- United States. Advisory Committee on Immunization Practices. Meningococcal Work Group. (15)
- United States. Advisory Committee on Immunization Practices. Mpox Vaccine Work Group. (9)
- United States. Advisory Committee on Immunization Practices. Mumps Work Group. (5)
- United States. Advisory Committee on Immunization Practices. Pertussis Vaccines Work Group. (18)
- United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group. (46)
- United States. Advisory Committee on Immunization Practices. Zoster Working Group. (5)
- United States. Animal and Plant Health Inspection Service. Agriculture Select Agent Program. (5)
- United States. Public Health Service. (7)
- University of Michigan. School of Public Health. (7)
- Valneva (5)
- Africa, Western (3)
- Alaska (2)
- Anniston, AL (1)
- Arctic Regions (2)
- Asia (2)
- Australia (1)
- California (1)
- Canada (2)
- Chamblee, GA (1)
- Chicago, Illinois (1)
- Cleveland, OH (1)
- Colorado (1)
- Finland (2)
- Greenland (2)
- Haiti (1)
- Herpes Zoster/prevention & control (1)
- Herpes Zoster Vaccine (1)
- Iceland (2)
- Illinois (1)
- Michigan (1)
- Norway (2)
- Ohio (1)
- Paraguay (1)
- Puerto Rico (6)
- Rhode Island (2)
- Sierra Leone (1)
- Sweden (2)
- Tennessee (1)
- Uniged States (1)
- United States (362)
- Washington (2)
- Washington, DC (1)
- West Virginia (1)
- Wisconsin (1)
-
Presentation (2270)
- :Centers for Disease Control and Prevention (U.S.)Jun 3, 2021:Intended for use in non-US healthcare settingsPublication date from document properties.emergency-considerations-ppe-508.pdf
- :Egan, Kathryn B. ;Courtney, Joseph G.October 30, 2020:cdc:103009cdc-decline-in-testing-blood-lead-rates-during-covid-pandemic-508.pdf
- :Jones, Robert ;Jarrett, JeffOctober 30, 2020:lab-perf-low-blood-lead-concentrations-508.pdf
- :Buchanan, SharundaOctober 30, 2020:cdc-lead-free-communities-initiative-508.pdf
- :National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of Tuberculosis Elimination.October 12, 2021:This slide series was developed as an accompaniment to the document Reported Tuberculosis in the United States, 2020Publication date from document pro...
- :National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Adolescent and School Health.12/30/2020:Publication date from document properties.DASHStrategicPlanPowerpoint508.pdf
- :Centers for Disease Control and Prevention (U.S.)July 8, 2020:interim-operational-considerations-hcw-covid19.pdf
- :Centers for Disease Control and Prevention (U.S.)No DescriptionJuly 8, 2020
- :Ben Beard, C.7/10/13:Publication date from document properties.ben_beard_ccvbd.pdf
- :National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Poxvirus and Rabies Branch.No DescriptionMarch 2014
- :Lynfield, Ruth ;Taylor, JillMay 7, 2019:AFM-taskforce-7May2019-H.pdf
- :Routh, JanellMay 7, 2019:CDC-AFM-Epidemiology-update-7May2019-H.pdf
- :National Healthcare Safety Network. ...June 13, 2019:Association for Professionals in Infection Control and Epidemiology 2019 Annual Conference. NHSN Members Meeting topics include NHSN Education and Tra...
- :Centers for Disease Control and Prevention (U.S.)10/11/16:Winnable battles:• Each area is a leading cause of illness, injury, disability, or death, and/or represents enormous societal costs• Evidence-base...
- :Task Force on Community Preventive Services (U.S.)9/20/10 | Community Guide slide modules:This slide presentation summarizes findings of the Task Force on Community Preventive Services for a set of systematic reviews on the effectiveness of...
- :Reynolds, Barbara (Barbara S.)June 28, 2016:The right person at the right time with the right message can save lives and reduce harm. The spokesperson personifies the organization. We will discu...
- :National Center for Chronic Disease Prevention and Health Promotion (U.S.), Division of Nutrition, Physical Activity, and Obesity.9/17/15:Definitions• Obesity: Body Mass Index (BMI) of 30 or higher.• Body Mass Index (BMI): A measure of an adult’s weight in relation to his or her he...
- :Martin, Rebecca6/3/16:Presentation at the Global Health Community meeting, June 3, 2016.Publication date from document properties.GHC-DC-Meeting_June-3_Martin.pd
- :Gould, Carolyn V. ;McDonald, CliffordNo Description12/23/09
- :National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases.2/9/16:Version 5.6.13This presentation is intended to be used to train laboratory workers about diagnosis and screening for early cryptococcal infection in H...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.